Improving New Learning and Memory in Traumatic Brain Injury
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01207375|
Recruitment Status : Completed
First Posted : September 22, 2010
Last Update Posted : April 3, 2015
|Condition or disease||Intervention/treatment||Phase|
|Traumatic Brain Injury||Behavioral: memory retraining exercises Behavioral: placebo control memory exercises||Not Applicable|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||120 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Triple (Participant, Investigator, Outcomes Assessor)|
|Official Title:||Improving New Learning in Traumatic Brain Injury: A Randomized Clinical Trial|
|Study Start Date :||January 2008|
|Actual Primary Completion Date :||October 2014|
|Actual Study Completion Date :||October 2014|
Experimental: experimental group
The experimental group will receive memory retraining exercises administered on a laptop computer twice a week for 5 weeks (10 training sessions).
Behavioral: memory retraining exercises
Memory retraining exercises will be administered on a laptop computer twice a week for 5 weeks (10 training sessions).
Placebo Comparator: Placebo control group
The placebo control group will receive placebo memory exercises administered on a laptop computer twice a week for five weeks (10 placebo control sessions).
Behavioral: placebo control memory exercises
Placebo control memory exercises will be administered on a laptop computer twice a week for five weeks (10 placebo control sessions.
- Scores on memory tests [ Time Frame: Three points in time: pre-treatment, immediately following treatment and 6 months after treatment is completed ]
- Reports of emotional functioning, memory functioning and quality of life [ Time Frame: Three points in time: pre-treatment, immediately following treatment and 6 months after treatment is completed ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01207375
|United States, New Jersey|
|Kessler Foundation Research Center|
|West Orange, New Jersey, United States, 07052|
|Principal Investigator:||Nancy D Chiaravalloti, Ph.D.||Kessler Foundation|